These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21879000)

  • 21. [Hereditary spherocytosis: one year study of erythrocyte membrane proteins].
    Tshilolo L; Kagambega F; Sztern B; Vertongen F; Gulbis B
    Rev Med Brux; 1998 Oct; 19(5 Pt 1):417-23. PubMed ID: 9844481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hereditary spherocytosis in neonates. Review of our caseload].
    Aramburu Arriaga N; Fernández Cuesta MA; Martínez González MJ; Astigarraga Aguirre I; Fernández-Teijeiro Alvarez A; Navajas Gutiérrez A; Piñán Frances MA
    An Esp Pediatr; 2000 Jun; 52(6):569-72. PubMed ID: 11003966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of mean sphered corpuscular volume for predicting hereditary spherocytosis.
    Broséus J; Visomblain B; Guy J; Maynadié M; Girodon F
    Int J Lab Hematol; 2010 Oct; 32(5):519-23. PubMed ID: 20136849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 6-Day-Old Male Infant with Severe Hyperbilirubinemia Diagnosed with Hereditary Spherocytosis at a Tertiary Hospital in East Java, Indonesia: A Diagnostic and Management Challenge in a Developing Country.
    Corebima BIRV; Monica C; Sulistijono E; Nugroho S; Wicaksono S; Hartiastuti SM
    Am J Case Rep; 2022 Nov; 23():e937416. PubMed ID: 36399434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Misdiagnosis of two cases of hereditary spherocytosis in a family and review of published reports.
    Deng Z; Liao L; Yang W; Lin F
    Clin Chim Acta; 2015 Feb; 441():6-9. PubMed ID: 25485852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening and early postnatal management strategies to prevent hazardous hyperbilirubinemia in newborns of 35 or more weeks of gestation.
    Maisels MJ
    Semin Fetal Neonatal Med; 2010 Jun; 15(3):129-35. PubMed ID: 20034861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk assessment for adverse outcome in term and late preterm neonates with bilirubin values of 20 mg/dL or more.
    Weng YH; Chiu YW; Cheng SW; Hsieh MY
    Am J Perinatol; 2011 May; 28(5):405-12. PubMed ID: 21365530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants.
    Keren R; Luan X; Friedman S; Saddlemire S; Cnaan A; Bhutani VK
    Pediatrics; 2008 Jan; 121(1):e170-9. PubMed ID: 18166536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does measuring the changes in TcB value offer better prediction of Hyperbilirubinemia in healthy neonates?
    Dalal SS; Mishra S; Agarwal R; Deorari AK; Paul V
    Pediatrics; 2009 Nov; 124(5):e851-7. PubMed ID: 19822593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Exchange transfusion and splenectomy for hyperbilirubinemia caused by hereditary spherocytosis in the neonatal period].
    Reddemann H
    Z Kinderheilkd; 1967; 100(3):192-204. PubMed ID: 5595863
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinico-hematological profile of hereditary spherocytosis: experience from a tertiary care center in North India.
    Kar R; Rao S; Srinivas UM; Mishra P; Pati HP
    Hematology; 2009 Jun; 14(3):164-7. PubMed ID: 19490762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yield of recommended blood tests for neonates requiring phototherapy for hyperbilirubinemia.
    Besser I; Perry ZH; Mesner O; Zmora E; Toker A
    Isr Med Assoc J; 2010 Apr; 12(4):220-4. PubMed ID: 20803881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal hyperbilirubinemia due to hereditary spherocytosis.
    Passi GR; Saran S
    Indian Pediatr; 2004 Feb; 41(2):199. PubMed ID: 15004312
    [No Abstract]   [Full Text] [Related]  

  • 34. Hyperbilirubinemia and bilirubin toxicity in the late preterm infant.
    Watchko JF
    Clin Perinatol; 2006 Dec; 33(4):839-52; abstract ix. PubMed ID: 17148008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison and evaluation of three screening tests of hereditary spherocytosis in Chinese patients.
    Tao YF; Deng ZF; Liao L; Qiu YL; Chen WQ; Lin FQ
    Ann Hematol; 2015 May; 94(5):747-51. PubMed ID: 25501660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for hereditary spherocytosis by use of automated erythrocyte indexes.
    Michaels LA; Cohen AR; Zhao H; Raphael RI; Manno CS
    J Pediatr; 1997 Jun; 130(6):957-60. PubMed ID: 9202619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcutaneous bilirubin nomogram for prediction of significant neonatal hyperbilirubinemia.
    Varvarigou A; Fouzas S; Skylogianni E; Mantagou L; Bougioukou D; Mantagos S
    Pediatrics; 2009 Oct; 124(4):1052-9. PubMed ID: 19786443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood cell parameters for screening and diagnosis of hereditary spherocytosis.
    Liao L; Xu Y; Wei H; Qiu Y; Chen W; Huang J; Tao Y; Deng X; Deng Z; Tao H; Lin F
    J Clin Lab Anal; 2019 May; 33(4):e22844. PubMed ID: 30945356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system.
    Eggert LD; Wiedmeier SE; Wilson J; Christensen RD
    Pediatrics; 2006 May; 117(5):e855-62. PubMed ID: 16651290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcutaneous bilirubin levels for the first 120 postnatal hours in healthy neonates.
    Fouzas S; Mantagou L; Skylogianni E; Mantagos S; Varvarigou A
    Pediatrics; 2010 Jan; 125(1):e52-7. PubMed ID: 20008429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.